These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 25275934)

  • 1. A pilot study on the Psoriasis Area and Severity Index (PASI) for small areas: Presentation and implications of the Low PASI score.
    Otero ME; van Geel MJ; Hendriks JC; van de Kerkhof PC; Seyger MM; de Jong EM
    J Dermatolog Treat; 2015; 26(4):314-7. PubMed ID: 25275934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inter-observer reliability of the PASI in a clinical setting.
    Cabrera S; Chinniah N; Lock N; Cains GD; Woods J
    Australas J Dermatol; 2015 May; 56(2):100-2. PubMed ID: 25753553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intra- and interobserver variability of image-based PASI assessments in 120 patients suffering from plaque-type psoriasis.
    Fink C; Alt C; Uhlmann L; Klose C; Enk A; Haenssle HA
    J Eur Acad Dermatol Venereol; 2018 Aug; 32(8):1314-1319. PubMed ID: 29569769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Why statistics matter: limited inter-rater agreement prevents using the psoriasis area and severity index as a unique determinant of therapeutic decision in psoriasis.
    Gourraud PA; Le Gall C; Puzenat E; Aubin F; Ortonne JP; Paul CF
    J Invest Dermatol; 2012 Sep; 132(9):2171-5. PubMed ID: 22592157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What are the best outcome measures for assessing plaque psoriasis severity? A systematic review of the literature.
    Puzenat E; Bronsard V; Prey S; Gourraud PA; Aractingi S; Bagot M; Cribier B; Joly P; Jullien D; Le Maitre M; Paul C; Richard-Lallemand MA; Ortonne JP; Aubin F
    J Eur Acad Dermatol Venereol; 2010 Apr; 24 Suppl 2():10-6. PubMed ID: 20443995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A study examining inter-rater and intrarater reliability of a novel instrument for assessment of psoriasis: the Copenhagen Psoriasis Severity Index.
    Berth-Jones J; Thompson J; Papp K;
    Br J Dermatol; 2008 Aug; 159(2):407-12. PubMed ID: 18565187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The reliability of three psoriasis assessment tools: Psoriasis area and severity index, body surface area and physician global assessment.
    Bożek A; Reich A
    Adv Clin Exp Med; 2017 Aug; 26(5):851-856. PubMed ID: 29068583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severity of Psoriasis Differs Between Men and Women: A Study of the Clinical Outcome Measure Psoriasis Area and Severity Index (PASI) in 5438 Swedish Register Patients.
    Hägg D; Sundström A; Eriksson M; Schmitt-Egenolf M
    Am J Clin Dermatol; 2017 Aug; 18(4):583-590. PubMed ID: 28342016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inter-rater concordance study of the PASI (Psoriasis Area and Severity Index).
    Faria JR; Aarão AR; Jimenez LM; Silva OH; Avelleira JC
    An Bras Dermatol; 2010; 85(5):625-9. PubMed ID: 21152786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized study to evaluate the efficacy and safety of adding topical therapy to etanercept in patients with moderate to severe plaque psoriasis.
    Lebwohl MG; Kircik L; Callis Duffin K; Pariser D; Hooper M; Wenkert D; Thompson EH; Yang J; Kricorian G; Koo J
    J Am Acad Dermatol; 2013 Sep; 69(3):385-92. PubMed ID: 23643256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Precision and reproducibility of automated computer-guided Psoriasis Area and Severity Index measurements in comparison with trained physicians.
    Fink C; Alt C; Uhlmann L; Klose C; Enk A; Haenssle HA
    Br J Dermatol; 2019 Feb; 180(2):390-396. PubMed ID: 30218575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rethinking the Psoriasis Area and Severity Index: the impact of area should be increased.
    Jacobson CC; Kimball AB
    Br J Dermatol; 2004 Aug; 151(2):381-7. PubMed ID: 15327545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study examining inter- and intrarater reliability of three scales for measuring severity of psoriasis: Psoriasis Area and Severity Index, Physician's Global Assessment and Lattice System Physician's Global Assessment.
    Berth-Jones J; Grotzinger K; Rainville C; Pham B; Huang J; Daly S; Herdman M; Firth P; Hotchkiss K
    Br J Dermatol; 2006 Oct; 155(4):707-13. PubMed ID: 16965419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Product of the Physician Global Assessment and body surface area: a simple static measure of psoriasis severity in a longitudinal cohort.
    Walsh JA; McFadden M; Woodcock J; Clegg DO; Helliwell P; Dommasch E; Gelfand JM; Krueger GG; Duffin KC
    J Am Acad Dermatol; 2013 Dec; 69(6):931-7. PubMed ID: 24054760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of PASI 75 and PASI 90 on quality of life in moderate to severe psoriasis patients.
    Abrouk M; Nakamura M; Zhu TH; Farahnik B; Koo J; Bhutani T
    J Dermatolog Treat; 2017 Sep; 28(6):488-491. PubMed ID: 28042711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atorvastatin for the treatment of plaque-type psoriasis.
    Faghihi T; Radfar M; Mehrabian Z; Ehsani AH; Rezaei Hemami M
    Pharmacotherapy; 2011 Nov; 31(11):1045-50. PubMed ID: 22026392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient measurement of psoriasis disease severity with a structured instrument.
    Fleischer AB; Rapp SR; Reboussin DM; Vanarthos JC; Feldman SR
    J Invest Dermatol; 1994 Jun; 102(6):967-9. PubMed ID: 8006462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tele-assessment of Psoriasis Area and Severity Index: a study of the accuracy of digital image capture.
    Singh P; Soyer HP; Wu J; Salmhofer W; Gilmore S
    Australas J Dermatol; 2011 Nov; 52(4):259-63. PubMed ID: 22070699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Standardizing training for psoriasis measures: effectiveness of an online training video on Psoriasis Area and Severity Index assessment by physician and patient raters.
    Armstrong AW; Parsi K; Schupp CW; Mease PJ; Duffin KC
    JAMA Dermatol; 2013 May; 149(5):577-82. PubMed ID: 23426158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of the self-administered psoriasis area and severity index in evaluating clinical and sociodemographic subgroups of patients with psoriasis.
    Sampogna F; Sera F; Mazzotti E; Pasquini P; Picardi A; Abeni D;
    Arch Dermatol; 2003 Mar; 139(3):353-8; discussion 357. PubMed ID: 12622629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.